Loading…

Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia

Background Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use. Aim To characterize the nature a...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical pharmacy 2024-12, Vol.46 (6), p.1410-1418
Main Authors: AlAmri, Lamaa S., Alluwaymi, Wafa S., Alghamdi, Badr G., Alghanim, Rashed A., Almordi, Afnan S., Hettah, Reham F., Almushaikah, Sahar F., AlShahrani, Asma M., Alshammri, Nouf T., Aldossari, Salma M., AlAwn, Leena I., Alsaleh, Nada A., AlShehri, Ghadah H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353
container_end_page 1418
container_issue 6
container_start_page 1410
container_title International journal of clinical pharmacy
container_volume 46
creator AlAmri, Lamaa S.
Alluwaymi, Wafa S.
Alghamdi, Badr G.
Alghanim, Rashed A.
Almordi, Afnan S.
Hettah, Reham F.
Almushaikah, Sahar F.
AlShahrani, Asma M.
Alshammri, Nouf T.
Aldossari, Salma M.
AlAwn, Leena I.
Alsaleh, Nada A.
AlShehri, Ghadah H.
description Background Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use. Aim To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA). Method A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs. Results A total of 1,165 MEs were reported. The majority of reported errors involved patients aged > 18 years old, with 72.2% ( n  = 841) being male. The central region was found to report errors more frequently (32.3%, n  = 376). Pharmacists were reported to detect errors most frequently (59.6%, n  = 695). MEs most often occurred in the prescribing stage (77.8%, n  = 906), with “missing prescription information” (30.1%, n  = 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%, n  = 351). The majority of errors did not reach the patients (92.3%, n  = 1,075), and those that did reach patients rarely resulted in harm (0.3%, n  = 2). Conclusion This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.
doi_str_mv 10.1007/s11096-024-01782-2
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11576782</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A816837873</galeid><sourcerecordid>A816837873</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353</originalsourceid><addsrcrecordid>eNp9UsFu1DAQjRCIVqU_wAFF4sIlxWM7ccIFrVZAkVr1AJytiTPZdZW1FzuptPwAv43TLdsWodoH22_ee9aMXpa9BnYGjKn3EYA1VcG4LBiomhf8WXbMObBCKYDnhzsTR9lpjNcsLVlxKOXL7Eg0UAqQ4jj7vVxjQDNSsHG0JuboutzgFCnmvs8DbX0YKUGD_4Vb66gINOCMbKizBkfrXU4h-BA_JC0Ou2hvleOa8kvrkmvYze9zwmFc5x2O2GKk3Lr8G06dzRcBW4uvshc9DpFO786T7MfnT9-X58XF1Zevy8VFYSQXYwE1StUa0zcEAkm0VU2l6HjD-j7hZdupjneihLqsDRjgLclKtqolk-qiFCfZx73vdmpTB4bcGHDQ22A3GHbao9WPK86u9crfaIBSVWnOyeHdnUPwPyeKo97YaGgY0JGfohaskUzKRs2fvf2Heu2nkIaUWCBYKWsJzT1rhQNp63qfPjazqV7UUNVC1Uok1tl_WGl3tLHGO-ptwh8J-F5ggo8xUH9oEpieI6T3EdIpQvo2Qnpu7s3D8RwkfwOTCGJPiKnkVhTuW3rC9g9Rb9LX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130548419</pqid></control><display><type>article</type><title>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</title><source>Springer Nature</source><creator>AlAmri, Lamaa S. ; Alluwaymi, Wafa S. ; Alghamdi, Badr G. ; Alghanim, Rashed A. ; Almordi, Afnan S. ; Hettah, Reham F. ; Almushaikah, Sahar F. ; AlShahrani, Asma M. ; Alshammri, Nouf T. ; Aldossari, Salma M. ; AlAwn, Leena I. ; Alsaleh, Nada A. ; AlShehri, Ghadah H.</creator><creatorcontrib>AlAmri, Lamaa S. ; Alluwaymi, Wafa S. ; Alghamdi, Badr G. ; Alghanim, Rashed A. ; Almordi, Afnan S. ; Hettah, Reham F. ; Almushaikah, Sahar F. ; AlShahrani, Asma M. ; Alshammri, Nouf T. ; Aldossari, Salma M. ; AlAwn, Leena I. ; Alsaleh, Nada A. ; AlShehri, Ghadah H.</creatorcontrib><description>Background Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use. Aim To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA). Method A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs. Results A total of 1,165 MEs were reported. The majority of reported errors involved patients aged &gt; 18 years old, with 72.2% ( n  = 841) being male. The central region was found to report errors more frequently (32.3%, n  = 376). Pharmacists were reported to detect errors most frequently (59.6%, n  = 695). MEs most often occurred in the prescribing stage (77.8%, n  = 906), with “missing prescription information” (30.1%, n  = 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%, n  = 351). The majority of errors did not reach the patients (92.3%, n  = 1,075), and those that did reach patients rarely resulted in harm (0.3%, n  = 2). Conclusion This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.</description><identifier>ISSN: 2210-7703</identifier><identifier>ISSN: 2210-7711</identifier><identifier>EISSN: 2210-7711</identifier><identifier>DOI: 10.1007/s11096-024-01782-2</identifier><identifier>PMID: 39153143</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Clozapine ; Internal Medicine ; Medical errors ; Medication errors ; Medicine ; Medicine &amp; Public Health ; Mental disorders ; Online databases ; Online health care information services ; Patients ; Pharmacy ; Primary care ; Research Article ; Schizophrenia</subject><ispartof>International journal of clinical pharmacy, 2024-12, Vol.46 (6), p.1410-1418</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 Springer</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353</cites><orcidid>0000-0001-7807-4470</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39153143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AlAmri, Lamaa S.</creatorcontrib><creatorcontrib>Alluwaymi, Wafa S.</creatorcontrib><creatorcontrib>Alghamdi, Badr G.</creatorcontrib><creatorcontrib>Alghanim, Rashed A.</creatorcontrib><creatorcontrib>Almordi, Afnan S.</creatorcontrib><creatorcontrib>Hettah, Reham F.</creatorcontrib><creatorcontrib>Almushaikah, Sahar F.</creatorcontrib><creatorcontrib>AlShahrani, Asma M.</creatorcontrib><creatorcontrib>Alshammri, Nouf T.</creatorcontrib><creatorcontrib>Aldossari, Salma M.</creatorcontrib><creatorcontrib>AlAwn, Leena I.</creatorcontrib><creatorcontrib>Alsaleh, Nada A.</creatorcontrib><creatorcontrib>AlShehri, Ghadah H.</creatorcontrib><title>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</title><title>International journal of clinical pharmacy</title><addtitle>Int J Clin Pharm</addtitle><addtitle>Int J Clin Pharm</addtitle><description>Background Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use. Aim To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA). Method A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs. Results A total of 1,165 MEs were reported. The majority of reported errors involved patients aged &gt; 18 years old, with 72.2% ( n  = 841) being male. The central region was found to report errors more frequently (32.3%, n  = 376). Pharmacists were reported to detect errors most frequently (59.6%, n  = 695). MEs most often occurred in the prescribing stage (77.8%, n  = 906), with “missing prescription information” (30.1%, n  = 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%, n  = 351). The majority of errors did not reach the patients (92.3%, n  = 1,075), and those that did reach patients rarely resulted in harm (0.3%, n  = 2). Conclusion This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.</description><subject>Clozapine</subject><subject>Internal Medicine</subject><subject>Medical errors</subject><subject>Medication errors</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental disorders</subject><subject>Online databases</subject><subject>Online health care information services</subject><subject>Patients</subject><subject>Pharmacy</subject><subject>Primary care</subject><subject>Research Article</subject><subject>Schizophrenia</subject><issn>2210-7703</issn><issn>2210-7711</issn><issn>2210-7711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UsFu1DAQjRCIVqU_wAFF4sIlxWM7ccIFrVZAkVr1AJytiTPZdZW1FzuptPwAv43TLdsWodoH22_ee9aMXpa9BnYGjKn3EYA1VcG4LBiomhf8WXbMObBCKYDnhzsTR9lpjNcsLVlxKOXL7Eg0UAqQ4jj7vVxjQDNSsHG0JuboutzgFCnmvs8DbX0YKUGD_4Vb66gINOCMbKizBkfrXU4h-BA_JC0Ou2hvleOa8kvrkmvYze9zwmFc5x2O2GKk3Lr8G06dzRcBW4uvshc9DpFO786T7MfnT9-X58XF1Zevy8VFYSQXYwE1StUa0zcEAkm0VU2l6HjD-j7hZdupjneihLqsDRjgLclKtqolk-qiFCfZx73vdmpTB4bcGHDQ22A3GHbao9WPK86u9crfaIBSVWnOyeHdnUPwPyeKo97YaGgY0JGfohaskUzKRs2fvf2Heu2nkIaUWCBYKWsJzT1rhQNp63qfPjazqV7UUNVC1Uok1tl_WGl3tLHGO-ptwh8J-F5ggo8xUH9oEpieI6T3EdIpQvo2Qnpu7s3D8RwkfwOTCGJPiKnkVhTuW3rC9g9Rb9LX</recordid><startdate>20241201</startdate><enddate>20241201</enddate><creator>AlAmri, Lamaa S.</creator><creator>Alluwaymi, Wafa S.</creator><creator>Alghamdi, Badr G.</creator><creator>Alghanim, Rashed A.</creator><creator>Almordi, Afnan S.</creator><creator>Hettah, Reham F.</creator><creator>Almushaikah, Sahar F.</creator><creator>AlShahrani, Asma M.</creator><creator>Alshammri, Nouf T.</creator><creator>Aldossari, Salma M.</creator><creator>AlAwn, Leena I.</creator><creator>Alsaleh, Nada A.</creator><creator>AlShehri, Ghadah H.</creator><general>Springer International Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7807-4470</orcidid></search><sort><creationdate>20241201</creationdate><title>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</title><author>AlAmri, Lamaa S. ; Alluwaymi, Wafa S. ; Alghamdi, Badr G. ; Alghanim, Rashed A. ; Almordi, Afnan S. ; Hettah, Reham F. ; Almushaikah, Sahar F. ; AlShahrani, Asma M. ; Alshammri, Nouf T. ; Aldossari, Salma M. ; AlAwn, Leena I. ; Alsaleh, Nada A. ; AlShehri, Ghadah H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clozapine</topic><topic>Internal Medicine</topic><topic>Medical errors</topic><topic>Medication errors</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental disorders</topic><topic>Online databases</topic><topic>Online health care information services</topic><topic>Patients</topic><topic>Pharmacy</topic><topic>Primary care</topic><topic>Research Article</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlAmri, Lamaa S.</creatorcontrib><creatorcontrib>Alluwaymi, Wafa S.</creatorcontrib><creatorcontrib>Alghamdi, Badr G.</creatorcontrib><creatorcontrib>Alghanim, Rashed A.</creatorcontrib><creatorcontrib>Almordi, Afnan S.</creatorcontrib><creatorcontrib>Hettah, Reham F.</creatorcontrib><creatorcontrib>Almushaikah, Sahar F.</creatorcontrib><creatorcontrib>AlShahrani, Asma M.</creatorcontrib><creatorcontrib>Alshammri, Nouf T.</creatorcontrib><creatorcontrib>Aldossari, Salma M.</creatorcontrib><creatorcontrib>AlAwn, Leena I.</creatorcontrib><creatorcontrib>Alsaleh, Nada A.</creatorcontrib><creatorcontrib>AlShehri, Ghadah H.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlAmri, Lamaa S.</au><au>Alluwaymi, Wafa S.</au><au>Alghamdi, Badr G.</au><au>Alghanim, Rashed A.</au><au>Almordi, Afnan S.</au><au>Hettah, Reham F.</au><au>Almushaikah, Sahar F.</au><au>AlShahrani, Asma M.</au><au>Alshammri, Nouf T.</au><au>Aldossari, Salma M.</au><au>AlAwn, Leena I.</au><au>Alsaleh, Nada A.</au><au>AlShehri, Ghadah H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia</atitle><jtitle>International journal of clinical pharmacy</jtitle><stitle>Int J Clin Pharm</stitle><addtitle>Int J Clin Pharm</addtitle><date>2024-12-01</date><risdate>2024</risdate><volume>46</volume><issue>6</issue><spage>1410</spage><epage>1418</epage><pages>1410-1418</pages><issn>2210-7703</issn><issn>2210-7711</issn><eissn>2210-7711</eissn><abstract>Background Clozapine has shown great efficacy in treating treatment‐resistant schizophrenia, but it is associated with a variety of medication- related safety problems. Despite this, there remains a lack of research on medication errors (MEs) associated with its use. Aim To characterize the nature and contributory factors of clozapine-related MEs reported from government hospitals and primary care centres in Saudi Arabia (SA). Method A cross-sectional analysis was carried out on MEs related to clozapine use reported to the General Administration of Pharmaceutical Care at the Ministry of Health (MOH) in Saudi Arabia between 2018 and 2022. The data were analysed descriptively to examine the nature and contributory factors of MEs. Results A total of 1,165 MEs were reported. The majority of reported errors involved patients aged &gt; 18 years old, with 72.2% ( n  = 841) being male. The central region was found to report errors more frequently (32.3%, n  = 376). Pharmacists were reported to detect errors most frequently (59.6%, n  = 695). MEs most often occurred in the prescribing stage (77.8%, n  = 906), with “missing prescription information” (30.1%, n  = 351) being the most frequent finding. The most frequent contributing factor was the lack of policy (33.1%, n  = 351). The majority of errors did not reach the patients (92.3%, n  = 1,075), and those that did reach patients rarely resulted in harm (0.3%, n  = 2). Conclusion This study identified areas for improvement which could expedite the development of remedial interventions to reduce the risk of errors.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39153143</pmid><doi>10.1007/s11096-024-01782-2</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7807-4470</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2210-7703
ispartof International journal of clinical pharmacy, 2024-12, Vol.46 (6), p.1410-1418
issn 2210-7703
2210-7711
2210-7711
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11576782
source Springer Nature
subjects Clozapine
Internal Medicine
Medical errors
Medication errors
Medicine
Medicine & Public Health
Mental disorders
Online databases
Online health care information services
Patients
Pharmacy
Primary care
Research Article
Schizophrenia
title Characteristics and causes of reported clozapine-related medication errors: analysis of the Ministry of Health database in Saudi Arabia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20causes%20of%20reported%20clozapine-related%20medication%20errors:%20analysis%20of%20the%20Ministry%20of%20Health%20database%20in%20Saudi%20Arabia&rft.jtitle=International%20journal%20of%20clinical%20pharmacy&rft.au=AlAmri,%20Lamaa%20S.&rft.date=2024-12-01&rft.volume=46&rft.issue=6&rft.spage=1410&rft.epage=1418&rft.pages=1410-1418&rft.issn=2210-7703&rft.eissn=2210-7711&rft_id=info:doi/10.1007/s11096-024-01782-2&rft_dat=%3Cgale_pubme%3EA816837873%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-18a47bccf9e13ae3b68e53d290ff7bc5bd7d2d351858c1c12be464b7becf7b353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130548419&rft_id=info:pmid/39153143&rft_galeid=A816837873&rfr_iscdi=true